endothelin-2 (Human) [3216]
endothelin-2 (Human)
| SMILES | CCC(C)C(NC(=O)C(CC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(Cc1c[nH]cn1)NC(=O)C1CSSCC(N)C(=O)NC(CO)C(=O)NC2CSSCC(NC(=O)C(CCC(=O)O)NC(=O)C(CCCCN)NC(=O)C(CC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(Cc3c[nH]c4ccccc34)NC(=O)C(CO)NC(=O)C(CO)NC2=O)C(=O)NC(C(C)C)C(=O)NC(Cc2ccc(O)cc2)C(=O)NC(Cc2ccccc2)C(=O)N1)C(=O)NC(C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)O)C(C)CC |
| InChIKey | MLFJHYIHIKEBTQ-UHFFFAOYSA-N |
| Sequence | CSCSSWLDKECVYFCHLDIIW |
| HELM | PEPTIDE1{C.S.C.S.S.W.L.D.K.E.C.V.Y.F.C.H.L.D.I.I.W}$PEPTIDE1,PEPTIDE1,3:R3-11:R3|PEPTIDE1,PEPTIDE1,1:R3-15:R3$$$ |
Chemical Properties
| Hydrogen bond acceptors | None |
| Hydrogen bond donors | None |
| Rotatable bonds | None |
| Log P | None |
| Molecular weight (Da) | None |
No bioactivity data available.
endothelin-2 (Human)
Drug properties
| Molecular type | Peptide |
| Physiological/Surrogate | Surrogate |
| Approved drug | No |
Distribution across phases (no. indications)
Phase I
0
Phase II
0
Phase III
0
Phase IV
0
Database connections
|
|